High quality global clinical trial supply companies by ClientPharma: Our values define who we are. They are the fundamental beliefs of our company’s organization as they guide our actions and behaviors. They influence the way we work with each other, the way we serve our clients, support our suppliers and champion patients’ health and well-being. We believe in our core company values because it’s in our DNA. It’s how we inherently work, each and every day! Our dedicated team has over 150 years of total experience in pharmaceutical supply solutions and clinical trial services. Find additional info on https://www.clientpharma.com/what-we-do/.
True commitment to patient safety: ClientPharma is also committed to proactively driving quality — not only because it’s the foundation from which the pharmaceutical industry has been built, but we also understand the significance of the patients’ safety and well-being. It’s our professional duty to service our clients’ needs with the utmost attention and care. CP also has a personal stake in supporting the development of future medicines that will treat and help eliminate life threatening diseases, ensuring we enhance our lives and those of our loved ones.
Supplying the world’s most respected biopharmaceutical companies – ClientPharma handles the numerous challenges of obtaining medicines quickly, in multiple lots, with ranging expiry dating – and we can source and supply from any region in the world! Our deep understanding and skill gives you the visibility needed to fulfill your clinical trial project requirements: Proactive market research and insights Procurement planning services; Worldwide sourcing capabilities; Collection and collation of multiple batches; Provision of batch documentation; Extensive experience and knowledge of emerging markets.
We are dedicated to delivering on point and on time, every time, no matter how technically challenging. With our preferred logistics partners, we offer warehousing solutions and specialist logistics to meet your clinical trial requirements. Global pharma warehousing and distribution capabilities: With our own state-of-the-art pharmaceutical warehouses strategically situated in major European and North American distribution hubs, as well as our global network of partner depots, ClientPharma provides you with your clinical trial supplies precisely where and when you need them. With access to our secure pharmaceutical warehousing, you can be confident in the integrity of your supply chain. All of our high-security storage conforms to strict cGDP guidelines. Read even more info on clientpharma.com.
Under this partnership, clients will now enjoy an expanded reach by leveraging ClientPharma’s global sourcing, procurement and distribution logistics while also having the ability to utilize the RxStudy CardTM, TrialCard’s virtual inventory supply solution that has been augmented to place physical inventories of medication at sites for protocol designs that require immediate dosing. This will cut supply costs by 50% and reduce clinical supply teams’ efforts by 80%. ClientPharma (CP) is a specialist global clinical trial supply company providing expertise in the procurement of comparators, rescue medications, adjuvant therapies, standard-of-care, reference drugs, medical devices, ancillaries, and matching placebos. From provision of clinical research samples to bulk supplies for global pivotal trials, the company has built a strong worldwide network to provide strategic commercial drug supply solutions for all stages of clinical programs. Reducing complexity and maximizing value – that’s our mission. CP is headquartered in the United Kingdom with offices and warehousing in the US, Ireland, Belgium, and China.
Supply and demand of pharmaceuticals are mutually exclusive. The supply chain is wholly reliant upon pharmaceutical companies being able to effectively forecast demand for a particular product. The process of forecasting is often made difficult when a new medicine has just been brought to market or rapid deployment of a drug needs to happen in response to a pandemic due to a lack of concrete evidence to base estimations on. In a survey of pharmaceutical Senior Managers it was reported that the majority of pharmaceutical companies had miscalculated demand for new medicines by up to 25%. Michael Lehmann, executive vice president of sales and marketing for Patheon, a global provider of outsourced pharmaceutical development and manufacturing said, “Making accurate demand forecasts is extremely challenging for pharmaceutical companies”.
